Community Head and Neck Cancer Knowledge, Engagement, Research, and Screening (CHECKERS): Protocol for a Community‐Engaged Approach to Head and Neck Cancer Prevention
Cancer Nexus · 2026
DOI: 10.1002/cnx2.70036 ↗Abstract
ABSTRACT Introduction Unequal access to care is associated with disparities in prevention, early detection, and outcomes of head and neck cancer (HNC), especially in underserved populations. Community‐engaged research (CEnR) aims to build capacity for community members to address health inequity via bidirectional partnerships with healthcare institutions. However, although HNC community screening events might increase HNC awareness, there is a paucity of HNC screening and prevention programs based on a community engagement framework. Methods and Analysis This pilot study utilizes mixed methodology in the development, implementation, and evaluation phases of a community engaged participatory research effort titled Community Head and Neck Cancer Knowledge, Engagement, Research and Screening (CHECKERS). The target community is a local faith‐based organization consisting primarily of an underserved immigrant population. An overseeing advisory board consisting of a transdisciplinary HNC team, community stakeholders, and community liaisons was assembled, and focus groups were held with community partners in the development phase to identify community resources/needs related to HNC prevention, risk factors, early detection, and health equity. Rapid analysis of the completed focus group sessions will inform the development of community education and screening events. Preliminary administration of the HNC knowledge and risk‐factor survey has begun and will continue during implementation. Quantitative and qualitative analysis of survey results, screening outcomes, and feedback from community stakeholders in the evaluation phase will be used to develop scalable, sustainable, and community‐driven interventions in the future. Ethics and Dissemination The described research study has been approved by the IRB of the parent institution. The results will be presented at relevant scientific meetings and disseminated through peer‐reviewed journals. Preliminary results will be used to develop interventions aimed at providing evidence of clinical benefits of mass screenings for preventing and detecting HNC, addressing the National Institutes of Health (NIH) NOT‐OD‐22‐179, Notice of Special Interest (NOSI): Addressing Evidence Gaps in Screening.
EUVIMED